These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 5464572)
1. [Clinical application of o.p' DDD to the case of adrenal cortex cancer]. Naruse T; Sasaki T; Yamaoka T; Matsuoka K; Nekita H Horumon To Rinsho; 1970 Mar; 18(3):241-4. PubMed ID: 5464572 [No Abstract] [Full Text] [Related]
2. [Hormonally acitve cancer of the adrenal cortex treated with o, p'-DDD]. Hartwig W; Massalski W; Kasperlik-Zaluska A; Migdalska B; Szamatowicz M; Jakowicki J Endokrynol Pol; 1968; 19(2):187-200. PubMed ID: 5668901 [No Abstract] [Full Text] [Related]
3. A case of adrenocortical cancer treated with O,P'-DDD. Sakauchi N; Kumaoka S; Naruke T; Abe O; Kusama M Endocrinol Jpn; 1969 Apr; 16(2):287-90. PubMed ID: 5819718 [No Abstract] [Full Text] [Related]
4. [Our experience with o,p'-DDD in the treatment of hypercorticism]. Mathieu De Fossey B; Luton JP; Bricaire H Ann Endocrinol (Paris); 1968; 29(1):93-102. PubMed ID: 4872638 [No Abstract] [Full Text] [Related]
5. [Treatment with o,p'-DDD of inoperable forms of malignant adrenal gland neoplasms]. Perevodchikova NI; Platinskiĭ LV; Kertsman VI Vopr Onkol; 1972; 18(11):24-9. PubMed ID: 4645074 [No Abstract] [Full Text] [Related]
6. Steroids in urine from a patient with adrenocortical carcinoma after treatment with op'-DDD. Gustafsson JA; Lisboa BP Steroidologia; 1971; 2(1):27-37. PubMed ID: 5133742 [No Abstract] [Full Text] [Related]
8. Conversion of virilization to feminization in a young girl with adrenal cortical carcinoma. Halmi KA; Lascari AD Cancer; 1971 Apr; 27(4):931-5. PubMed ID: 5574080 [No Abstract] [Full Text] [Related]
9. Treatment of adrenocortical carcinoma with o,p'-DDD. Hoffman DL; Mattox VR Med Clin North Am; 1972 Jul; 56(4):999-1012. PubMed ID: 5034421 [No Abstract] [Full Text] [Related]
10. Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients. Hutter AM; Kayhoe DE Am J Med; 1966 Oct; 41(4):581-92. PubMed ID: 5923599 [No Abstract] [Full Text] [Related]
12. Effects of O,p'DDD and aminoglutethimide on metastatic adrenocortical carcinoma. Bochner F; Lloyd HM; Roeser HP; Thomas MJ Med J Aust; 1969 Apr; 1(16):809-12. PubMed ID: 5769733 [No Abstract] [Full Text] [Related]
13. Testosterone and androstenedione production rates in patients with metastatic adrenal cortical carcinoma. Bardin CW; Lipsett MB; French AM J Clin Endocrinol Metab; 1968 Feb; 28(2):215-20. PubMed ID: 5636152 [No Abstract] [Full Text] [Related]
14. o,p'DDD therapy in invasive adrenocortical carcinoma. Becker D; Schumacher OP Ann Intern Med; 1975 May; 82(5):677-9. PubMed ID: 1137262 [TBL] [Abstract][Full Text] [Related]
15. Adrenal cortical carcinoma. Clinical features of 138 patients. Hutter AM; Kayhoe DE Am J Med; 1966 Oct; 41(4):572-80. PubMed ID: 5923598 [No Abstract] [Full Text] [Related]
16. [Effect of chlodithane (o,p'-DDD) on transcortin binding ability in Itsenko-Cushing's disease]. Tron'ko MD Fiziol Zh; 1970; 16(6):844-5. PubMed ID: 5520073 [No Abstract] [Full Text] [Related]
17. [Effect of the adrenal cortex blockader O,P'-dichlorodiphenyldichloroethane (O,P'-DDD) on the acetylation processes in the liver]. Shevchenko AV; Kosbel' NN Vrach Delo; 1974 Jan; (1):72-4. PubMed ID: 4468586 [No Abstract] [Full Text] [Related]
18. [Adrenal adenocarcinoma]. Vaisman S; Pizzi T; Rivera G; Del Rio A; Beresi V; Del Pozo H Rev Chil Pediatr; 1971 Mar; 42(3):175-81. PubMed ID: 5114331 [No Abstract] [Full Text] [Related]
19. [Description of a case of virilizing adrenal cortex neoplasm. Considerations on the hormone picture in basal and dynamic conditions]. Faggiano M; Minozzi M; Nunziata V; Lombardi G; Franza C Folia Endocrinol; 1966 Oct; 19(5):592-606. PubMed ID: 6013250 [No Abstract] [Full Text] [Related]
20. [Drug therapy of adrenal gland hyperfunction]. Raith L Dtsch Med Wochenschr; 1972 Mar; 97(12):475-7. PubMed ID: 5017395 [No Abstract] [Full Text] [Related] [Next] [New Search]